Physician profile
Mark Zucker
NPI 1356319180
$44,187.41
in general payments reported to CMS, 2019-2025
32 companies · $3,476 in 2025
The $3,476 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,128 · 2020: $181 · 2021: $175 · 2022: $612 · 2023: $9,661 · 2024: $27K · 2025: $3,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Travel and Lodging: $6,550 · Food and Beverage: $3,531 · Education: $69.81 · Consulting Fee: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,890.00 |
| Travel and Lodging | $6,550.37 |
| Food and Beverage | $3,531.29 |
| Education | $69.81 |
| Consulting Fee | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $34,941.57 | 2021-2025 | Verquvo, Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $2,101.45 | 2022-2025 | |
| Abbott Laboratories | $1,801.05 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $1,025.77 | 2019-2025 | |
| Medtronic Vascular, INC. | $901.78 | 2019 | |
| Cvrx, INC. | $737.90 | 2024 | Barostim Neo System |
| Alnylam Pharmaceuticals INC. | $446.62 | 2022-2025 | Amvuttra |
| Impulse Dynamics (USA) INC. | $239.63 | 2021-2025 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $234.29 | 2023-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $221.04 | 2019-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $211.36 | 2019-2024 | |
| Bridgebio Pharma, INC. | $186.70 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals Lp | $175.32 | 2019-2024 | Wainua |
| Boston Scientific Corporation | $137.66 | 2019-2021 | |
| Pfizer INC. | $136.69 | 2019-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.78 | 2019-2025 | Jardiance |
| Medtronic, INC. | $96.98 | 2021 | |
| Amgen INC. | $81.18 | 2019-2024 | Repatha |
| Scpharmaceuticals INC. | $71.64 | 2024 | |
| Janssen Pharmaceuticals, INC | $46.64 | 2019-2022 | |
| Glaxosmithkline, LLC. | $44.00 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $37.70 | 2019 | |
| Sensible Medical Innovations INC | $34.91 | 2025 | Reds System |
| Philips North America LLC | $33.82 | 2024-2025 | (5050) Extended Holter, Extended Holter |
| Eurofins Viracor, LLC | $32.27 | 2025 | |
| Amarin Pharma, INC. | $25.69 | 2019-2022 | |
| Sobi, INC | $16.67 | 2021 | |
| Kamada Ltd. | $16.14 | 2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $14.12 | 2022 | |
| Astellas Pharma US INC | $13.71 | 2019 | |
| Akcea Therapeutics, INC. | $13.45 | 2019 | |
| Allergan, INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Zucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.